The Immunohematology Market to Grow Extensively Owing to the Rise in Demand for Blood- and Plasma-derived Products
Transparency Market Research in its new report titled, “Immunohematology Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025,” provides key insights on the immunohematology market. The new report anticipates that the rise in the demand for blood- and plasma-derived products such as platelets, immunoglobulin, and plasma coupled with rapid increase in the global disease burden will drive the immunohematology market during the forecast period i.e, 2017-2025. The number of patients with different hematological and other chronic diseases is also increasing rapidly across the world. This is likely to raise the number of surgical procedures in the near future, consequently propelling the demand for blood transfusions, says the report.
The report states that the demand for advanced immunohematology tests is anticipated to increase during the forecast period to maintain the quality standards and safety profiles during blood transfusions. Awareness among the general public regarding the importance of blood compatibility and transfusion-related diseases is increasing due to the development of health care infrastructure, government campaigns, and increasing per capita income in developed as well as developing countries. Furthermore, awareness among patients about proper compatibility tests for transfusion is also growing. Increasing health care expenditure and rising worldwide concerns about medical safety are also anticipated to drive the global immunohematology market.
The TMR report has segregated the global immunohematology market on the basis of product into analyzers and reagents. The analyzers segment has been sub-segmented into automatic analyzers and semi-automatic/non-automatic analyzers. In terms of application, the global immunohematology market is divided into blood typing and antibody screening. In accordance with end-user, the market is classified into hospitals, academic & research institutes, diagnostic & reference laboratories, and blood banks. The hospitals segment is expected to remain dominant during the forecast period, due to increasing usage of automated analyzers with high throughput in hospitals.
Based on regional perspective, the report has segmented the global immunohematology market into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2016 and TMR expects the region to continue its dominance between 2017 and 2025. Growth of the market in North America is primarily ascribed to the increased funding by governments and the private sector and large volumes of blood transfusions. In addition, increased focus on research by pharmaceutical companies and well-established health care infrastructure are major factors fueling the market in the region.
The market in Europe is expected to grow at a significant CAGR from 2017 to 2025. Europe held the second-largest market share in 2016. High adoption and usage of superior-quality diagnostics and treatments is one of the major factors driving the market in the region. The report attributes the growth to increasing number of diagnostic laboratories and blood banks, rising government funding for research activities, and growing application of immunohematology in transfusion safety in the region. Asia Pacific is one of the rapidly developing regions in the world. High per capita income has increased the consumption of blood products in the region.
Major companies profiled in the report are included in this report and these are Bio-Rad Laboratories, Inc., Grifols, S.A., Ortho Clinical Diagnostics, IMMUCOR, INC., Abbott Laboratories, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Merck KGaA, and Siemens Healthineers.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. We are leaders in analytics, research, and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a preeminent provider of cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who hold a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence. TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
